# H101 Plus TACE for r/m HNSCC

> **NCT07398664** · PHASE2 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Oncolytic Virus
- TACE

## Interventions

- **DRUG:** H101
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT07398664
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-15
- **Primary completion:** 2027-02-15
- **Final completion:** 2028-02-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07398664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07398664, "H101 Plus TACE for r/m HNSCC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07398664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*